Tags: earth sciencenatural disasterspatient-centricitymedicine researchpatient involvement
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Oxford Drug Design achieves in vivo validation for novel cancer treatment - about 1 month ago | |
2 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | ||
3 | Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia | Current Landscape of Bispecific Therapies for RRMM - 3 months ago | |
4 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 8 months ago Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant - about 1 year ago Futile Immunotherapy for Cancer Grows More Common - about 1 year ago | |
5 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
6 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | ||
7 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
8 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Pharma’s ‘it’ therapy — a new drug class gaining steam - 6 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - over 1 year ago | |
9 | Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. | ||
10 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA |